H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH |
Catalog No.GA22168 |
CRGDFPASSC is a cyclic RGD-containing decapeptide which binds to the fibrinogen receptor on the platelet surface. This analog with Phe substituted for Ser at position 5 was found to be 3 times more active (IC?? = 2.5 µM) as a platelet aggregation inhibitor than CRGDSPASSC.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 166184-23-2
Sample solution is provided at 25 µL, 10mM.
CRGDFPASSC is a cyclic RGD-containing decapeptide which binds to the fibrinogen receptor on the platelet surface. This analog with Phe substituted for Ser at position 5 was found to be 3 times more active (IC50 = 2.5 µM) as a platelet aggregation i
Average Rating: 5
(Based on Reviews and 35 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *